Black Diamond Therapeutics Inc. (BDTX), a clinical-stage oncology company, is scheduled to release two data updates for its lead drug candidate, BDTX-1535, this quarter.
BDTX-1535, which works by inhibiting the mutated EGFR protein involved in cancer cell growth, is currently being tested in the two phase II trials in non-small cell lung cancer.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.